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Abstract
Bacteriophage PRD1 is an icosahedral dsDNA virus with a diameter of 740 Å and an outer protein shell composed of 720 copies of major
coat protein P3. Spike complexes at the vertices are composed of a pentameric base (protein P31) and a spike structure (proteins P5 and
P2) where the N-terminal region of the trimeric P5 is associated with the base and the C-terminal region of P5 is associated with
receptor-binding protein P2. The functionality of proteins P3 and P5 was investigated using insertions and deletions. It was observed that
P3 did not tolerate changes whereas P5 tolerated changes much more freely. These properties support the hypothesis that viruses have core
structures and functions, which remain stable over time, as well as other elements, responsible for host interactions, which are evolutionally
more fluid. The insertional probe used was the apex of exposed loop 4 of group B meningococcal outer membrane protein PorA, a medically
important subunit vaccine candidate. It was demonstrated that the epitope could be displayed on the virus surface as part of spike protein P5.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Recent advances in probing the structure of PRD1, a
dsDNA bacterial virus with an internal membrane, have
revealed intriguing similarities to human adenovirus and
have led to proposals of common ancestry (Belnap and
Steven, 2000; Benson et al., 1999, 2002; Hendrix, 1999) as
well as made PRD1 amenable to trials for use as an epitope
display system. The icosahedral virion, with a diameter of
740 Å from vertex to vertex, has an external protein layer
composed of 240 copies of P3 coat protein trimers arranged
on a pseudo T  25 lattice (Butcher et al., 1995). The
icosahedral vertices have a pentameric protein P31 that
forms a base for the extending spike structure built of
trimeric spike protein P5 and receptor-binding protein P2
(Bamford and Bamford, 2000; Caldentey et al., 2000; Grahn
et al., 1999; Rydman et al., 1999). The high-resolution
structure of P3 reveals a monomer with two connected
-barrels, V1 and V2, similar to adenovirus hexon (Benson
et al., 1999, 2002). V1 displays a tower region extending
from the virus surface, which is also seen as a protrusion in
cryo-electron microscopy reconstructions (Fig. 1). Beneath
the protein coat resides the viral membrane, which closely
follows the icosahedral shape of the capsid (Butcher et al.,
1995). The 15-kbp-long genome is located within the mem-
brane vesicle, a device used by the virus to deliver its DNA
to gram-negative host cells (Bamford and Mindich, 1982;
Grahn et al., 2002; Lundstro¨m et al., 1979; Rydman and
Bamford, 2000).
The cryo-electron microscopy density map of the virion
combined with the high-resolution structure of the major
coat protein yielded a quasi-atomic model for the capsid
(depicted in Fig. 1b). This model gave information on in-
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teractions between the coat and the membrane as well as on
vertex structure (San Martı´n et al., 2001, 2002). Recent
crystallization of the entire 66-MDa virion (Bamford et al.,
2002) and current efforts to resolve its high-resolution struc-
ture provide a solid basis for probing the virion through
genetic approaches and allow modeling of insertions. The
vertex spike has resisted structural analysis because of sym-
metry mismatch (trimeric P5 associates with pentameric
P31) and flexibility. Icosahedral averaging applied in both
electron microscopy-based image reconstructions as well as
in X-ray analyses abolishes the spike signal. Purified recep-
tor-binding protein P2 has been crystallized (Xu et al., 2000,
2003) but no crystals of P5 have been obtained, except for
the distal C-terminal domain. The structure of the flexible
P5 trimer, however, has been examined with solution scat-
tering techniques (Sokolova et al., 2001). In this study, the
Fig. 1. (a) Major coat protein P3 trimer high-resolution structure (orange; Benson et al., 2002) fitted to the 25-Å reconstruction of PRD1 virion (San Martı´n
et al., 2001). Density corresponding to P3 is shown in transparent gray and vertices are in red. (b) A close-up of an icosahedral facet. The position of one
P3 trimer is depicted. V1 and V2 correspond to the -barrels of one monomer. (c) Secondary structure elements in the P3 monomer. The P3 fold is shown
from the side. The upper part of the molecule points outward and the lower part toward the viral membrane. Positions of epitope insertions are denoted. Amino
acids replaced by meningococcal epitope structure (pdb:1MPA; van den Elsen et al., 1997) are shown in blue (inset).
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structure of the spike protein was probed by making inser-
tions and deletions at several positions.
Several epitope display systems have been developed in
the past 15 years using infective viruses (De Berardinis et
al., 2000; de la Cruz et al., 1988; Maruyama et al., 1994;
Porta et al., 1994; Rose et al., 1994; Smith et al., 1994;
Sternberg and Hoess, 1995; Jiang et al., 1997) and virus-like
particles (Belyaev and Roy, 1992; Gedvilaite et al., 2000;
Gilbert et al., 1997; Kratz et al., 1999; Mastico et al., 1993;
Pumpens and Grens, 1999; Rueda et al., 1999). Detailed
understanding of the PRD1 system makes it a promising
candidate for displaying epitopes on virion surfaces or pu-
rified structural proteins. PRD1 has several advantages as an
epitope carrier: (1) the high copy number of the epitope is
thought to be important in eliciting strong immunological
responses; (2) 720 copies of the major coat protein and
about 40 copies of the spike protein are exposed on the
PRD1 surface; (3) knowledge of the coat protein atomic
structure supports rational design; and (4) PRD1 membrane
components have adjuvant properties. The epitope probe
selected for this study is one of two major immunological
determinants of the PorA protein (P1.16 subtype) of group
B Neisseria meningitidis, the bacteria that cause severe
meningitis in humans. Several previous attempts to use
PorA for vaccine development have not been successful.
Results
Modeling of the meningococcal peptide to the surface
loops of the coat protein P3
The epitope used in this study was the PorA protein from
P1.16 subtype N. meningitidis. PorA forms an amphipathic
-barrel embedded in the outer membrane with surface-
exposed antigenic loops. TKDTNNNL peptide in loop 4
defines the P1.16 antigenic specificity. The structure of a
fluorescein-conjugated form TKDTNNNLC has been
solved by X-ray crystallography (van den Elsen et al., 1997)
and it forms a -hairpin in complex with the antigen-
binding fragment of monoclonal antibody (Mab) MN12H2.
Four loops in the tower region of the large -barrel V1 of
PRD1 major coat protein P3 were considered for insertion
of this peptide (Fig. 1c): BC1 (48–53), DE1 (79–95), FG1
(114–158), and HI1 (197–222). Loops DE1 and FG1 are on
top of the tower region and thus clearly on the most external
part of the protein. Loop BC1 is to the side of V1 and loop
HI1 is intertwined on the surface of the protein and contains
a short -helix (HI1-). The known natural variants of this
part of the protein, T77K and E224K, fall near these loop
regions (Benson et al., 2002). The C–C distance between
the terminal residues of the epitope is 5.5 Å in the crystal
structure, and similar C–C pairs were searched in selected
surface loops of P3. Distances in the five selected pairs
ranged from 5.3 to 6.2 Å. Insertions were modeled to these
five sites (Fig. 1c), models were energy-minimized and
evaluated for steric hindrance. Since no clashes were ob-
served, all five sites were chosen for epitope insertions. In
contrast to P3, in which all loops are between the -strands
belonging to two different -sheets, the native loop struc-
ture in PorA is formed between neighboring strands in one
sheet. Assuming that epitope structure is largely indepen-
dent of its environment, the epitope could obtain the struc-
ture recognized by the antibody when inserted into P3
surface loops.
Epitope insertion interferes with the biological activity of
coat protein P3
The biological activity of the recombinant coat proteins
was assessed by complementation analysis, in which the
increase in titer is due to complementation and recombina-
tion. The titer of sus14 mutant virus (P3) was determined
on a bacterial strain carrying a plasmid with the recombi-
nant hybrid coat protein gene. Complementation titers are
presented in Table 1. Introduction of a new restriction en-
zyme site in the genomic region corresponding to the sur-
Table 1
Biological activity of the modified major coat P3 protein as measured by complementation test
Position of the modificationa Deleted wt sequence Epitope insertion sus14 titer (pfu ml1)
None, positive control 3.0  1010
No P3, negative control 3.0  105
BC1 (A50G) 2.4  1010
DE1 (A81G) 2.3  1010
HI1 (A208P) 4.0  108
BC1 (F47–R52) DPAN TKDTNNNLC 6.6 107
DE1 (N79–A84) HATE TKDTNNNLC 3.2 108
FG1 (I154–T159) AAGA TKDTNNNLC 1.9 108
HI1 (A204–N209) AVGA TKDTNNNLC 9.9 109
HI1- (A218–C223) GAAD TKDTNNNLC 4.5 108
DE1 (N79–A84) HATE AAATKDTNNNLCAAA 1.1 107
HI1 (A204–N209) AVGA AAATKDTNNNLCAAA 3.3 107
a The secondary structure of the modification site is given (Benson et al., 2002). Point mutations and the residues adjacent to insertion-deletions are
indicated in parentheses.
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face loop in the insertion vectors altered the amino acid
sequence in three loops: BC1, DE1, and HI1. In BC1 and
DE1, an alanine was changed into a glycine. This change
did not affect the complementation ability of P3 whereas the
change from alanine to proline in loop HI1 had a severe
effect. The titer dropped by two orders of magnitude com-
pared to wild-type (wt) P3 (Table 1). Table 1 shows that
insertion of the meningococcal peptide into surface loops
strongly interfered with P3 complementation ability. The
titer with TKDTNNNLC in loop HI1 was the highest, with
approximately 30% of wt P3 titer. This construct was used
in trials to introduce the epitope coding sequence into the
viral genome by homologous recombination as described
elsewhere (Bamford and Bamford, 2000). However, these
attempts failed. The remaining hybrid proteins gave titers
two to three orders of magnitude lower than the wt control
(Table 1). Because of the low biological functionality of the
hybrid proteins, the corresponding genes were not selected
for introduction into the viral genome.
Recombinant hybrid proteins were expressed and puri-
fied further for immunological analyses. Escherichia coli
cells containing plasmids encoding wt or hybrid P3 protein
were grown as described under Materials and methods. At
37°C, all P3 protein was found almost entirely in the par-
ticulate fraction with only trace amounts in the supernatant.
P3 yield was approximately 40–50 mg l1. At 18°C,90%
of wt P3 was soluble, whereas hybrid protein constructs
could not be rescued from the particulate fraction (data not
shown). Immunoblotting with meningococcal P1.16
epitope-specific mouse monoclonal antibody MN12H2 con-
firmed presence of epitope in the hybrid (Fig. 2). This
monoclonal antibody reacted also with a 40-kDa host pro-
tein present in the whole cell sample (Fig. 2), but not in the
purified virus preparate.
The vertex protein P5 has a domain structure where the
carboxyl-terminal domain and the linker region are
accessible from outside
Because the major coat protein derivatives aggregated
when produced from expression vectors, the ability of tri-
meric vertex protein P5 to carry the meningococcal P1.16
epitope was probed. By using amber mutant viruses sus691,
sus692, and sus693 to express truncated versions of the
vertex protein (depicted in Fig. 3), it was shown that the
amino terminal region is associated with the capsid (Bam-
ford and Bamford, 2000). Amber mutants were analyzed
further by immuno-centrifugation to determine which por-
tion of the carboxyl-terminal domain protrudes from the
virion surface. The assay was first optimized using wt PRD1
particles and polyclonal serum against the vertex protein P5.
In optimized antibody/virus ratios (1/50 antiserum dilution)
an additional, faster moving zone was detected in the rate
zonal sucrose gradient containing virus particles (Fig. 4).
Fig. 2. A Western blot of E. coli cells with overexpressed wild-type and
hybrid coat proteins P3 with the meningococcal epitope in different surface
loops. Proteins were detected by monoclonal antibody (MN12H2) against
the meningococcal P1.16 epitope. The antibody cross-reacts with a 40-
kDa host protein which is marked with an asterisk. Soluble (S) and
particulate (P) fractions are prepared as described under Materials and
methods. Loops are named as in Fig. 1.
Fig. 3. Schematic presentation of the domain structure of trimeric P5 (Bamford and Bamford, 2000; Caldentey et al., 2000). Locations of amber codons (in
sus691, sus692 and sus693) as well as locations of inserted epitopes (1–8; for the exact location of the insertion see Table 2) are marked with arrows. The
amino acid sequence of the linker region is indicated. Underlined is the collagen-like motif as well as the polyglycine stretch.
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The new zone corresponded to aggregates of two PRD1
particles as approximated from the sedimentation velocity
and negative stain EM analysis (Fig. 4). In a control exper-
iment with antiserum against the coat protein P3, all virus
material was always detected either in a zone with the
velocity of single virus particles or in the pellet fraction,
depending on the antibody concentration. The double virus
zone was also obtained by using antisera against two other
vertex proteins, P2 and P31 (data not shown). The assay
with P5-specific antiserum was repeated by using purified
sus691 (Fig. 4), sus692 and sus693 particles carrying P5
truncations and, as a control, sus690 particles entirely miss-
ing P5. Sus690 particles did not form the double virus zone
under the conditions used whereas all particles carrying
truncated P5 did. The results show that even the shortest
version of P5 with 149 amino acids is accessible to anti-
bodies on a virion surface.
P5 proteins carrying the meningococcal epitope in their
carboxyl-terminal domain are biologically active
Secondary structure prediction for protein P5 (PHDsec;
Rost and Sander, 1993, 1994) resulted in a model with a
repeating pattern of loops and -strands, similar to the
-spiral fold in adenovirus fiber shaft (van Raaij et al.,
1999). It was shown earlier that the P5 amino terminus is
homologous to P31 (Caldentey et al., 2000). Optimal align-
ment of P5 and P31 amino termini was calculated to predict
structure more reliably. For the carboxyl terminus no ho-
mologous proteins exist, so secondary structure was pre-
dicted based on P5 sequence alone. Insertion sites were
chosen to match predicted loop areas. Positions of the con-
structed meningococcal insertions are indicated in Table 2
and Fig. 3. Two insertions were made within the amino-
terminal domain, two within the flexible linker region, and
four within the carboxyl-terminal domain. The biological
activity of the hybrid proteins was tested by complementa-
tion analysis. The titer of P5 mutant sus690 was deter-
mined on a bacterial strain carrying different recombinant
plasmids with hybrid gene V (Table 2). Hybrid vertex pro-
teins with N-terminal insertions were not able to rescue the
defect in sus690, giving titers only slightly higher than
background. Linker region insertions, 3 and 4 (Fig. 3; Table
2), resulted in titers of one order of magnitude higher than
background. In contrast, all hybrid proteins with C-terminal
insertions rescued the defect in P5 (Table 2). The best
insertion, 5 (Fig. 3; Table 2), produced a titer almost as high
as the positive control (wt gene V). In this construct, the
epitope was inserted between adjacent amino acids (T200
and D201) whereas in the other three functional constructs,
wt amino acids were replaced (Table 2).
Fig. 4. Analysis of the virus particles with the immunocentrifugation
method. A photograph from a rate zonal sucrose gradient: (A) PRD1 wt,
(B) PRD1 wt  P5, (C) sus691 (P5 truncation)  P5 (note the faster
sedimentation of the spike-less virus). (D) A negative staining electron
micrograph from faster sedimenting antibody-treated wt virus band depict-
ing that the majority of the particles are twins (circled). The bands are
marked at the left with single and double hexagons indicating the nature of
the sedimenting particles.
Table 2
Biological activity of the deletion and hybrid P5 vertex proteins carrying the meningococcal epitopes as measured by complementation test
Position of the modificationa Deleted wt sequence Epitope insertion sus690 titer (pfu ml1)
None, positive control 5.0  1011
No P5, negative control 4.0  105
1 (S27–L37) VIEIAGTEV GTKDTNNNL 1.0 106
2 (N113–F114) GTKDTNNNL 1.0 106
3 (E153–G163) SLLDTTSEP GTKDTNNNL 2.0 106
4 (Y181–D183) G GTKDTNNNL 6.0 106
5 (T200–D201) GTKDTNNNL 3.0 1011
6 (A219–G229) NALTDFDLS GTKDTNNNL 1.0 109
7 (A251–1259) GKSGLYQ GTKDTNNNL 6.0 109
8 (R276–F284) VKYGSSD GTKDTNNNL 3.0 1010
G8 (S190–V199) GGGGGGGG 8.7 1011
collagen (S123–V142) GIKGDKGDPGAPGPAGGT 3.1 1011
a Numbers 1–8 refer to the position of the modification as in Fig 3, G8 and collagen refer to deleted polyglycine and collagen-like motif, respectively.
Residues adjacent to modifications are indicated in parentheses.
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Analysis of the recombinant spike protein
Hybrid gene V from construct 5, which gave the best com-
plementation titer, was recloned into an expression vector,
overexpressed, and then purified as described under Materials
and methods. In a pattern similar to wt, the overexpressed re-
combinant protein eluted in several peaks from an anion ex-
change and gel filtration column, with peaks representing mul-
timeric forms of the protein as shown earlier (Caldentey et al.,
2000). This indicates that the overexpressed recombinant spike
protein is capable of forming dimers, trimers, and nonamers by
interacting via the amino-terminal domain as shown for the wt
protein (Sokolova et al., 2001). The purified recombinant pro-
tein was analyzed by Western blotting using P5-specific anti-
serum and Mab MN12H2, which recognizes the meningococ-
cal P1.16 epitope. Both gave a strong signal, confirming that
the purified spike protein carried the epitope (Fig. 5).
Recombinant PRD1 gene V coding the meningococcal
epitope can be inserted into the viral genome resulting in
viable virus
The hybrid gene V carrying the epitope between amino
acids T200 and D201 (construct 5; Fig. 3) was introduced
into the genome of PRD1. The presence of the epitope in
purified virions was confirmed by Western blotting using
Mab MN12H2 against the meningococcal P1.16 epitope
(Fig. 5). The presence of all spike complex proteins (P2, P5,
and P31) in normal amounts was also confirmed using
specific antisera (Fig. 5). This demonstrates that the particle
is replication competent with no variations in protein stoi-
chiometry. The stability of the recombinant virus was fol-
lowed for 3 months by titering the phage every second
week. No difference in stability compared to wt particles
was detected (data not shown). However, compared to the
wt virus, a difference in the binding of the recombinant
virus to the host cell was observed (Fig. 6). The binding rate
constant of the recombinant virus was 0.29  0.07 min1,
which is significantly smaller than that of wt (0.48  0.02
min1).
Probing the role of the linker region in the spike
protein P5
Protein P5 domain structure is depicted in Fig. 3. To
analyze the function of the collagen-like motif and the eight
glycine residue stretch, these sequences were deleted by
site-directed mutagenesis from plasmids containing wt gene
V. Resulting plasmids with deletions collagen and G8
were able to complement the defect in sus690, a P5-defi-
cient mutant, revealing that these gene V deletion constructs
were functional (Table 2). The constructs were further in-
troduced from the plasmid into the phage genome by ho-
mologous recombination as described under Materials and
Fig. 6. Binding of hybrid virus PRD1-[GTKDTNNNL]-1 and deletion
mutants PRD1-[P5G8] and PRD1-[P5collagen] to host cells compared
to wt PRD1. Fitted exponential model curves are shown with measured
values. The fraction of bound virus particles in the plateau is indicated on
the right. Binding rate constants are given in parentheses (units are in
min1).
Fig. 5. A Western blot of purified hybrid spike protein P5 (lane A), hybrid
PRD1 carrying the epitope (lane B), and wt PRD1 (lane C). Lanes were cut
from the membrane and detected with antibodies as marked on top of each
lane. Polyclonal antibodies P2, P5, and P31 are against corresponding
PRD1 vertex proteins and monoclonal MN12H2 recognizes the meningo-
coccal P1.16 epitope. The hybrid protein is migrating more slowly, allow-
ing separation from wild type.
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methods. The resulting phages, PRD1-[P5collagen] and
PRD1-[P5G8], were purified and analyzed by Western
blotting with antisera against vertex components P2, P5, and
P31. All vertex proteins were present in wt amounts (data
not shown). Specific infectivity was also comparable to that
of wt virus (1.0  1013 plaque-forming units [pfu] mg1 of
protein; Walin et al., 1994). This shows that the deletion
proteins, in addition to the epitope insertion construct (see
above), can be incorporated into viable particles when pro-
duced under the physiological conditions of a standard
PRD1 infection. The kinetics of the binding of the two spike
protein deletion mutant particles to the host receptor was
determined (Fig. 6). Curves obtained from an exponential
model fitted experimental data very well (regression coef-
ficients 0.98). In equilibrium, 96 0.72% of the wt virus
is bound. Deletion of the collagen-like motif had a severe
effect on binding efficiency (only 44  2.1% of virus
particles bound at equilibrium), although the binding rate
constant (0.67  0.18 min1) was comparable to that of wt
(0.48  0.019 min1). With deletion of eight glycine resi-
dues, the rate constant (0.20  0.038 min1) was signifi-
cantly lower than that of wt but binding efficiency was
nearly sustained (83  4.6%).
Immunological properties of the hybrid proteins and viruses
Enzyme-linked immunosorbent assay (ELISA) experi-
ments, with monoclonal antibodies (MN12H2, MN5C11G,
62D12-8) and polyclonal antibody (HH898) confirmed that
the P1.16 epitope is present and exposed on recombinant
proteins purified in a denatured form (data not shown). The
immunogenicity of the constructions was tested in mice and
the postimmunization sera were analyzed by ELISA. De-
spite good immunogenicity of wt coat protein, only mar-
ginal antibody responses to both native porA (capsular po-
lysaccharide-depleted whole meningococcal cells) and
denatured recombinant porA protein (isolated from inclu-
sion bodies) were observed (data not shown).
In contrast to the immunoblotting studies with the spe-
cific Mab MN12H2 (Fig. 5), the PRD1-[GTKDTNNNL]-1
recombinant phage failed to show positive reaction in
ELISA with the panel of P1.16-specific murine monoclonal
and polyclonal antibodies tested (data not shown). This
suggests that the inserted TKDTNNNL epitope is not prop-
erly exposed or the antibodies do not recognize its confor-
mation. This is further supported by the fact that neither the
purified hybrid protein nor the hybrid phage were able to
raise proper immune response in either mice or rabbits.
Discussion
Several alterations were introduced to the coat (P3) and
spike (P5) proteins of PRD1. Although only a short inser-
tion was used and its position was modeled to the most
distal exposed loops of the coat protein, the functionality of
P3 was severely impaired in four cases out of five as
measured by their ability to complement P3-deficient viral
particles. Alterations in the function of the epitope-carrying
P3 proteins are most likely explained by an increased pro-
pensity to misfold, since the overexpressed recombinant
proteins were not soluble at 18°C, while the wt protein was.
On the other hand, it was possible to introduce both inser-
tions and deletions into selected sites in the spike protein
without drastically diminishing its function, except in cases
where insertions were located in regions involved in an-
choring the spike protein to the viral vertex. It is concluded
that characteristics of altered P3 and P5 molecules are in
line with the “self” hypothesis (Bamford, 2003; Bamford et
al., 2002). According to this hypothesis, related viruses
contain conserved elements (like the coat protein fold and
its potential to form closed shells) that evolve slowly and
may date back to viruses that existed before current domains
of life were separated. It is proposed that these conserved
elements form an innate viral “self” and can be used to
classify viruses within lineages. Other elements may have
evolved much more rapidly, allowing parasitic viruses to
respond quickly to host cell changes. In contrast to surface
loops of adenovirus hexon, all surface loops in PRD1 major
coat protein are very short. In addition, they do not seem to
tolerate even short insertions. This suggests that the PRD1
coat protein is in a deep evolutional minimum. In PRD1-like
viruses isolated from around the world, few changes are
found in the coat protein primary sequence (Benson et al.,
2002). In contrast, the extensive variable surface loops of
adenovirus hexon change whenever the immune recognition
system of the host is altered, and thus are not counted
among adenoviral-conserved elements. Because the PRD1
capsid remains on the cell surface upon infection, it is
proposed that PRD1 surface loops have been optimized to
build a stable structure, and thus are conserved. On the other
hand, the spike protein P5 is part of the receptor recognition
complex; it must change rapidly to guarantee continuous
and efficient binding to host cells.
The flexible spike structures composed of proteins P5
and P2 (Bamford and Bamford, 2000; Caldentey et al.,
2000; Sokolova et al., 2001) are not visible in icosahedrally
averaged image reconstructions of PRD1 (Fig. 1; San
Martı´n et al., 2001) and are thus difficult to study. P5
alterations illustrate several key points (Figs. 3 and 6).
Removal of the eight glycine residues decreased adsorption
rate but had little effect on adsorption efficiency, since after
reaching a plateau, the fraction of bound virus particles was
the same as for wt. This suggests reduced spike flexibility
and, consequently, reduction in receptor searching space.
Removal of the collagen motif had little effect on adsorption
rate but adsorption efficiency was reduced to less than
one-half. No reduction of receptor-binding protein P2 was
observed, reflecting the possible role of the collagen motif
in irreversible receptor binding and/or entry. Interestingly,
in adenovirus with long fibers, such as types 2 and 5, both
flexibility and shaft domain length seem to affect receptor
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usage (Chiu et al., 2001). Recently, it was proposed that the
distal region flexibility of reovirus attachment protein 1, a
functionally related protein, has an important role in recep-
tor binding (Chappell et al., 2002). Organization of the
P2–P5 complex is not known but recent advances in solving
its structure (Xu et al., 2000, 2003) as well as the structure
of the distal C-terminus of P5 (R. Tuma, personal commu-
nication) will lead to further understanding of structural
details and help to interpret these results.
The nine amino acid structural probe of the group B
meningococcal outer membrane protein PorA P1.16 epitope
was selected because of its size and medical relevance as a
vaccine candidate. A viral epitope carrier such as PRD1
with 720 coat and approximately 40 spike proteins could
potentially elicit immunological responses against this se-
vere bacterial pathogen with no effective subunit vaccine
yet developed. The epitope was successfully inserted into
four surface loops of P3 as indicated by Western blot and
ELISA analyses. These chimeric proteins lost biological
activity, however, and it was not feasible to construct a virus
particle expressing the meningococcal epitope as part of the
coat protein. Denatured chimeric P3 proteins can, however,
be produced for immunological studies. Insertion of the
meningococcal epitope into spike protein P5 yielded a func-
tional protein and the corresponding construction could be
incorporated into the viral genome, allowing expression of
the epitope on the virus particle. This is proof of principle
that a foreign epitope can be inserted into P5 and expressed
on purified virion surfaces.
Immunization of mice or rabbits with chimeric denatured
P3 protein or purified viral particles carrying chimeric P5
proteins elicited strong immune responses against carrier
proteins but only weak responses against the meningococcal
epitope inserted within the HI1 loop in protein P3. Other
chimeric constructs did not show relevant responses. The
ELISA signal of virus-associated epitopes was low, sug-
gesting the epitope was not properly exposed. When the
high-resolution structure of the C-terminal distal region of
P5 is available, a better understanding of the epitope loca-
tion will be obtained and a more rational design of P5
insertion sites allowed.
In this study, the feasibility of using PRD1 as a peptide
display system was demonstrated. Further insights into the
structure of the receptor-binding complex will permit a
more detailed search for viable surface regions. The high
yield and considerable purity of PRD1 particles (Walin et
al., 1994) make this carrier complex an alternative for ex-
pressing multiple copies of epitopes on particle surfaces.
Materials and methods
Bacteria, phages, and plasmids
Bacterial strains and phages used in the study are listed
in Table 3. The cells were grown in Luria-Bertani (LB)
medium (Sambrook and Russell, 2001). When appropriate,
tetracycline (10 g ml1), cloramphenicol (25 g ml1), or
kanamycin (25 g ml1) was added. Wt PRD1 and the
recombinant phages PRD1-[GTKDTNNNL]-1, PRD1-
[P5G8], and PRD1-[P5collagen] were propagated on
Salmonella enterica DS88 and the amber mutants sus14,
sus690, sus692, and sus693 on their suppressor strains (Ta-
ble 3). Strain SL5676 was used in the phage adsorption
experiments as a receptorless control. E. coli DH5,
HB101, and HMS174 were used as cloning hosts and
HMS174(DE3) as an expression host. Marker exchange by
homologous recombination between the PRD1 genome and
the recombinant plasmid was performed in E. coli
JM107(pJB15) and complementation experiments were car-
ried out using strain HMS174(pLM2). Virus was purified as
described earlier (Bamford and Bamford, 1991) except that
the virus zone from the rate zonal sucrose gradient was
further purified by ion exchange chromatography. For this
either a Sartobind ion exchange filter D100X (Sartorius) or
a MemSep DEAE cellulose filter (Millipore) was used (Wa-
lin et al., 1994). Plasmids used in the study are listed in
Table 4.
Site-directed mutagenesis
Single-step recombination PCR (Jones and Howard,
1991) was used to obtain site-directed changes in low-copy-
number plasmid pSU18-based vectors carrying gene III
(pSH2) and V (pJB500 and pSH38) encoding proteins P3
and P5, respectively. Two primers having complementary
5	 regions were used to produce a linear product with
homologous ends containing designed changes. Amplifica-
tions were performed in 50-l volume of standard buffer
with 2.5 U cloned Pfu polymerase (Stratagene), 25 pmol of
primers, and 250 M each deoxynucleoside triphosphate
(dNTP). Thermal cycling (30 cycles) was performed with
the following parameters: 95°C for 30 s (initial denaturation
for 2 min), 60–70°C for 2 min, and 72°C for 7 min. The
methylated circular parental DNA was digested at 37°C for
at least 2 h with 10 U of DpnI prior to transformation into
DH5 cells.
Silent point mutations were designed using EMBOSS
software package (Rice et al., 2000) to create new restric-
tion enzyme sites. A new site was introduced by Quick
Change into plasmid pSH2 regions coding for the surface
loops of the coat protein P3 (BC1, DE1, FG1, HI1, and
HI1-), resulting in insertion vectors (pJTH7, 1, 17, 13, and
15, respectively; Table 4). The DNA sequence encoding the
meningococcal PorA P1.16 surface epitope (TKDT-
NNNLC) was inserted into all five vectors by recombination
PCR resulting in plasmids pJTH19, 21, 23, 25, and 27
(Table 4). A longer sequence with alanine residues flanking
the meningococcal epitope (AAATKDTNNNLCAAA) was
introduced in two loops, DE1 and HI1, resulting in plasmids
pJTH39 and 41, respectively (Table 4). Clones were
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screened by the disappearance of the restriction enzyme site
unique to the vector. An overall frequency of approximately
85% of correct clones was observed. The same method was
used for insertion of TKDTNNNLC epitope encoding se-
quence into eight different sites in gene V (pJTH70, 72,
74, 76, 78, 80, 82, and 84) and for deletion of the eight
glycine residues (pSH12) and the collagen-like motif
(pJTH109). Point mutations resulting in new restriction
sites for screening clones were introduced simultaneously.
Plasmid pJB500 or pSH38 was used as a template. Mutated
plasmids were screened by the appearance of new restric-
tion enzyme sites. Modifications were further verified by
DNA sequencing.
Expression and analysis of the recombinant hybrid P3
proteins
To overexpress hybrid coat proteins, inserts from low-
copy-vector clones (pJTH19, 21, 23, 25, and 27) were
recloned into high-copy-vector pJJ2, resulting in plasmids
pSH21, 16, 17, 18, 19, and 20, respectively (Table 4).
Hybrid proteins and corresponding wt protein (pSH21) were
expressed in E. coli K12 HMS174(DE3). Overnight cultures
at 37 or 28°C were diluted 1/20 into L broth and growth was
continued at 37 or 18°C, respectively. Cells were grown to
approximately 3  108 cells ml1 and recombinant protein
production was induced with 1 mM isopropyl--D-thioga-
lactopyranoside (IPTG). Growth was continued for 3 h at
37°C or overnight at 18°C, after which cells were collected
by centrifugation (Sorvall SS34 or GS3, 5°C, 10 min, 5000
rpm) and resuspended into 1/10 of original volume of 20
mM Tris-HCl, pH 7.4, buffer. Cells were broken by soni-
cation for 2 min followed by a centrifugation step (Heraeus
Biofuge Pico, RT [room temperature], 3 min, 10,000 rpm).
Supernatant and pellet fractions were applied to SDS-PAGE
analysis. Specificity of the protein bands was confirmed by
Western blotting. P3 was detected either with monoclonal
antibodies 3N180, 3N81, and 3T74 (Bamford et al., 1993)
or with a polyclonal antibody against P3 and the meningo-
coccal peptide with the monoclonal antibody MN12H2 (van
den Elsen et al., 1997) specific for the PorA P1.16 serosub-
type epitope.
For large-scale purification of inclusion bodies, cells
were disrupted by two passages through a French pressure
cell (15,000 psi). Triton X-100 was added to a final con-
centration of 1%, and after 1 h incubation at RT, inclusion
bodies were separated by centrifugation. Inclusion bodies
were further purified by washing twice with detergent so-
lution (phosphate-buffered saline [PBS] containing 3% Tri-
ton X-100, 2% Tween 20, 0.2% SDS) for 1 h at RT. This
resulted in 60–70% homogeneity, as estimated from Coo-
massie blue-stained SDS-PAGE. Final purification was per-
Table 3
Bacteria and phages used in the study
Genotype or description Reference
Bacteria
Escherichia coli
DH5 F recA1 endA gyrA96 relA1 hsdR17 supE44 thi (lacZYA-argF)
U169 80d lacZM15 
Sambrook and Russell, 2001
HB101 recA1 endA hsdS pro leu thi lacY galK xyl mtl1 ara14 supE44 Boyer and Roulland-Dussoix, 1969
HMS174 F recA hsdR, cloning host Campbell et al., 1978
HMS174(pLM2) Nonsuppressor host for complementation assay
HMS174(DE3) encodes T7 polymerase gene, expression host
JM107(pJB15) RecA, encodes LacZ
 fragment, host for recombination Bamford and Bamford, 2000
Salmonella enterica serovar
Typhimurium
SL5676 H2, H1-1::Tn10 (Tcs), used as a nonbinding control in binding assay B.A.D. Stocker, Stanford University,
Palo Alto, California
DS88 SL5676 (pLM2), nonsuppressor host for PRD1 Bamford and Bamford, 1990
PSA(pLM2) supE, suppressor host for sus14, sus690, and sus692 Mindich et al., 1982
DB7154(pLM2) supD, suppressor host for sus691 and sus693 Winston et al., 1979
Phages
PRD1
wt Olsen et al., 1974
sus14 Amber mutation in gene III Mindich et al., 1982
sus690 Amber mutation in gene V, Q4am Bamford and Bamford, 2000
sus691 Amber mutation in gene V, S150am Bamford and Bamford, 2000
sus692 Amber mutation in gene V, Q184am Bamford and Bamford, 2000
sus693 Amber mutation in gene V, S204am Bamford and Bamford, 2000
[LacZ]-15 Insertion in gene V, M206-LacZ-Y207 This study
[GTKDTNNNL]-1 Insertion in gene V, T200–GTKDTNNNL-D201 This study
[P5G8] Deletion in gene V, G191–G198 This study
[P5collagen] Deletion in gene V, G124–T141 This study
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formed using preparative SDS-PAGE and passively eluting
protein from gel slices into PBS containing 0.1% SDS. This
resulted in nearly 100% homogeneity.
Expression and purification of the hybrid P5 protein
The hybrid gene V with the meningococcal epitope in-
sertion giving the best complementation titer was recloned
from pJTH78 into pET24 vector as an EcoRI–HindIII frag-
ment resulting in plasmid pSN17. HMS174(DE3)(pSN17)
cells were grown at 37°C to a density of about 2  108
colony forming units (cfu) ml1. After addition of IPTG to
a final concentration of 1 mM, incubation was continued for
3 h. Cells were collected by centrifugation (Sorvall GS3
rotor, 5000 rpm, 10 min, 5°C), resuspended in 20 mM
Tris-HCl, pH 7.2, 5% (v/v) glycerol (1/100th of the original
culture volume), and frozen at 70°C. After thawing, cells
were disrupted by a French press as described above and
debris was removed by centrifugation (Sorvall SS34 rotor,
8000 rpm, 20 min, 5°C). The supernatant was further
cleared (Beckman Ti50 rotor, 30,000 rpm, 2 h, 5°C) and
proteins were precipitated by adding ammonium sulfate to
27% saturation. Precipitated material was collected (Sorvall
SS34 rotor, 10,000 rpm, 30 min, 5°C) and resuspended in 20
mM Tris-HCl pH 7.2, 50 mM NaCl, and dialyzed overnight
at 5°C against the same buffer. After clearing (Sorvall SS34
rotor, 10,000 rpm, 10 min, 5°C) the solution was applied to
HI TRAP Q column (Pharmacia) and proteins were eluted
with a linear 50 mM–1 M NaCl gradient in the same buffer.
Fractions containing the hybrid P5 protein were collected
and loaded on a Hi-Load Superdex 200 16/60 gel-filtration
column (Pharmacia) equilibrated with 20 mM Tris-HCl, pH
7.2, 150 mM NaCl. Peak fractions containing hybrid P5
spike protein were collected.
Table 4
Plasmids used in the study
Plasmid Description (nucleotide coordinates in PRD1 genomea) Reference
pLM2 (Kmr)b, encodes PRD1 receptor Mindich et al., 1976
pJB15 Tcr, encodes PRD1 receptor Ha¨nninen et al., 1997
pSU18 Cmr, p15A, cloning vector Bartolome´ et al., 1991
pSH2 pSU18  III  XXII (8595–9944) This study
pJTH7 pSH2/C8743G, SmaI site in the BC1 loopc, A50G This study
pJTH1 pSH2/C8836G, KpnI site in the DE1 loop, A81G This study
pJTH17 pSH2/G9059C, KspI site in the FG1 loop This study
pJTH13 pSH2/G9216C, ApaI site in the HII loop, A208P This study
pJTH15 pSH2/T9257C, EclXI site in the HII- This study
pJTH19 pJTH7/F47-TKDTNNNLC-R52 This study
pJTH21 pJTH1/N79-TKDTNNNLC-A84 This study
pJTH23 pJTH17/I154-TKDTNNNLC-T159 This study
pJTH25 pJTH13/A204-TKDTNNNLC-N209 This study
pJTH27 pJTH15/A218-TKDTNNNLC-C223 This study
pJTH39 pJTH1/N79-AAATKDTNNNLCAAA-A84 This study
pJTH41 pJTH13/A204-AAATKDTNNNLCAAA-N209 This study
pJJ2 Apr, ColE1, expression vector Ojala et al., 1993
pSH21 pJJ2  III  XXII (8595–9944) This study
pSH16 pJJ2  III  XXII (8595–9944) from pJTH19 This study
pSH17 pJJ2  III  XXII (8595–9944) from pJTH21 This study
pSH18 pJJ2  III  XXII (8595–9944) from pJTH23 This study
pSH19 pJJ2  III  XXII (8595–9944) from pJTH25 This study
pSH20 pJJ2  III  XXII (8595–9944) from pJTH27 This study
pJB500 pSU18  XXXI  V (4894-6309) Bamford and Bamford, 2000
pJTH70 pJB500/S27-GTKDTNNNL-L37 This study
pJTH72 pJB500/N113-GTKDTNNNL-F114 This study
pJTH74 pJB500/E153-GTKDTNNNL-G163 This study
pJTH76 pJB500/Y181-GTKDTNNNL-D183 This study
pJTH78 pJB500/T200-GTKDTNNNL-D201 This study
pJTH80 pJB500/A219-GTKDTNNNL-G229 This study
pJTH82 pJB500/A251-GTKDTNNNL-I259 This study
pJTH84 pJB500/R276-GTKDTNNNL-F284 This study
pSN12 pJB500/G191-G198 This study
pSH38 pSU18  V (5287-6309) This study
pJTH109 pSH38/G124-T141 This study
pET24 Kmr, ColE1, expression vector This study
pSN17 pET24  V (5287-6309) from pJTH78 This study
a Accession No. M69077.
b Km, kanamycin; Tc, tetracyclin; Cm, chloramphenicol; Ap, ampicillin; r, resistance.
c The secondary structure of the modification site is given (Benson et al., 2002).
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Construction of the recombinant phages
In vivo homologous recombination was used to intro-
duce hybrid or deleted gene V from plasmids into the virus
genome as earlier described (Bamford and Bamford, 2000).
The meningococcal insertion from pJTH78 and the collagen
motif deletion from pJTH109 were recombined into the
genome of PRD1 sus693. Recombination of the 8 glycine
residue deletion from pSN12 into the virus was performed
using the PRD1-[LacZ-]-15 phage, which was first con-
structed using the method described earlier (Bamford and
Bamford, 2000). Phages and plasmids were allowed to re-
combine in vivo and resulting viruses were plated on S.
enterica DS88 cells. The DNA from the plaques was ana-
lyzed by PCR. Plaques were first resuspended in 500 l of
20 mM Tris-HCl, pH 7.2, after which the material was
divided into two aliquots. One aliquot was saved for phage
recovery and the other was boiled for 5 min in the presence
of 1% SDS to disrupt phage particles. A 1/10 dilution of this
solution was used as a template in a PCR. Successful inser-
tion of the epitope was confirmed by using primers designed
to hybridize to the inserted DNA sequence and gene V,
resulting in a specific 740-bp-long product. For the two
deletion mutants, primers were designed to hybridize to
gene V and the resulting PCR product was screened by the
appearance of a new restriction site, which was originally
designed into the primer used in the mutagenesis (NheI
in the 8 glycine deletion and MluNI in the collagen
motif deletion). Recombinant phages were purified as
earlier described (Bamford and Bamford, 1991; Walin et al.,
1994).
Phage adsorption assay
Cells were grown in LB medium to optimal adsorption
phase (2 109 cfu ml1; Kotilainen et al., 1993). Host cells
(100 l) were mixed with approximately 300 phage parti-
cles and the mixture was incubated at 22°C for 1, 5, 10, and
15 min. Cells were collected by centrifugation (5000 rpm, 3
min, 22°C) and the number of free (nonadsorbed) phage
particles was determined by plating supernatant on S. en-
terica DS88 cells.
Analytical and immunological methods
SDS-PAGE was performed as earlier described
(Olkkonen and Bamford, 1989). Proteins were either stained
with Coomassie brilliant blue or transferred for Western
blotting onto a polyvinylidene difluoride membrane (Milli-
pore) and detected with antibodies. Polyclonal antisera rec-
ognizing phage PRD1, proteins P3 (Ha¨nninen et al., 1997),
P5 (Ha¨nninen et al., 1997), P2 (Grahn et al., 1999), or P31
(Rydman et al., 1999), and the monoclonal antibody
MN12H2 (van den Elsen et al., 1997) specific for the me-
ningococcal P1.16 PorA sequence TKDTNNNL were used.
The chemiluminescent detection of peroxidase-conjugated
secondary antibodies was performed using either the
ECLplus (Amersham) or the Super Signal West Pico system
(Pierce). Protein concentration of recombinant protein and
virus preparates was determined using bovine serum albu-
min as a standard (Bradford, 1976).
Surface location of truncated P5 proteins was analyzed
by an immunocentrifugation assay. One hundred microliters
of the MemSep DEAE cellulose-purified phage particles
(corresponding to 9.5  1011 particles and 100 g of pro-
tein) was incubated with 100 l of antiserum dilution (1/5,
1/50) at 22°C for 60 min. The mixture was analyzed in a
linear 5–20% (w/v) rate zonal sucrose gradient in 10 mM
KPHO4, pH 7.2 (Sorvall TH641, 24,000 rpm, 55 min,
15°C). The light scattering zones were illuminated in the
BioComp fraction collector sample chamber and photo-
graphed. Negative staining was carried out using 1% am-
monium molybdate (pH 6.5) and the micrographs were
recorded using a JEOL 1200 EX electron microscope op-
erating at 60 kV.
Antigenicity of recombinant proteins and virus was an-
alyzed by ELISA using meningococcal P1.16 epitope-
specific monoclonal antibodies (MN12H2, MN5C11G,
62D12-8; National Institute of Public Health and the Envi-
ronment [RIVM], The Netherlands) and polyclonal mouse
serum (HH898, KTL, Finland). Peroxidase-conjugated rab-
bit immunoglobulins (Ig) to mouse Igs (P0260, Dako Im-
munoglobulins), diluted 1:4000 in PBS–10% Fetal calf se-
rum, were used as secondary antibodies. 3,3	,5,5	-
tetramethylbenzidine (Sigma; 0.4 mM in 0.11 M sodium
acetate buffer containing 0.006% H2O2) was used as a
substrate.
To test immunogenicity of the meningococcal insertion
sequence displayed on purified hybrid P3 protein, or on P5
protein on the virus surface, the antigen was introduced into
mice. Groups of five 7-week-old outbred female Neu:NIH/s
mice were injected three times subcutaneously with 20 g
of protein or 20 or 50 g of the virus in a final volume of
0.2 ml on Days 0, 28, and 56. Control animals received only
PBS. Freund’s complete adjuvant was used in the first and
AlPO4 in the second and third immunization. The animals
were bled on Day 63 and the sera analyzed by ELISA for
antibody responses to the wild-type PRD1 and to the me-
ningococcal P1.16 epitope both in the denatured (recombi-
nant protein isolated from inclusion bodies) and in the
native form (capsular polysaccharide-depleted whole me-
ningococcal cells) (Nurminen et al., 1992).
The immunogenicity of hybrid P5 protein and the recom-
binant PRD1-[GTKDTNNNL]-1 was further tested in rab-
bits. In the primary immunization the antigen was injected
subcutaneously with Freund’s complete adjuvant followed
by two boosters in Freund’s incomplete adjuvant. A dose of
200 and 500 g of the antigen was used for hybrid protein
and phage particles, respectively. Boosters were given at
3-week intervals and serum was collected 2 weeks after the
final booster.
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